← Leaderboards
Prasanna Jagannathan
Stanford University
$10,796,952
Attributed
$17,147,307
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,147,307 · 6
By mechanism
U01$13,686,540 · 2
R01$2,116,487 · 2
T32$686,830 · 1
K23$657,450 · 1
Top collaborators
- Atul J Butte8 shared
- Bryan R Greenhouse8 shared
- Ashraful Haque2 shared
- David A Relman2 shared
- Robert Michael Angelo1 shared
Most similar at Stanford University
Same institution · by research overlap
- Scott Dexter Boyd$18,651,021
- Matthew S Bogyo$24,780,518
- Henrik Toft Sãrensen$427,392
- Anna Thuy Nhu Nguyen$97,776
- Robert Michael Angelo$7,860,542
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseImmunityInfectionImmune ResponseImmuneChildMalariaBloodUgandaAreaMorbidity - Disease RateClinical TrialsAffectRandomizedFalciparum MalariaCohortAdaptive Immune ResponseVaccinesImmunologyCellsMortalityParasitesMalaria InfectionInflammatory
Grant awards (25)
Innate-adaptive immune bridging in gravidity-dependent immunity against placental malaria: a multi-omics approach$789,442
R01 · FY2025 · AI · contact PI
Enhancing immunity to malaria in young children with effective chemoprevention$734,418
U01 · FY2025 · AI · contact PI
Deciphering mechanisms of CD4+ T cell-dependent clinical immunity to repeated Plasmodium infections$643,506
R01 · FY2025 · AI · contact PI
Enhancing immunity to malaria in young children with effective chemoprevention$513,257
U01 · FY2025 · AI · contact PI
Applied Genomics in Infectious Diseases$351,736
T32 · FY2025 · AI · contact PI
Enhancing immunity to malaria in young children with effective chemoprevention$1,240,005
U01 · FY2024 · AI · contact PI
Computational models of naturally acquired immunity to falciparum malaria$1,177,782
U01 · FY2024 · AI
Deciphering mechanisms of CD4+ T cell-dependent clinical immunity to repeated Plasmodium infections$683,539
R01 · FY2024 · AI · contact PI
Applied Genomics in Infectious Diseases$335,094
T32 · FY2024 · AI · contact PI
Enhancing immunity to malaria in young children with effective chemoprevention$1,252,084
U01 · FY2023 · AI · contact PI
Computational models of naturally acquired immunity to falciparum malaria$1,183,322
U01 · FY2023 · AI
Enhancing immunity to malaria in young children with effective chemoprevention$1,240,701
U01 · FY2022 · AI · contact PI
Computational models of naturally acquired immunity to falciparum malaria$1,189,438
U01 · FY2022 · AI
Enhancing immunity to malaria in young children with effective chemoprevention$1,283,030
U01 · FY2021 · AI · contact PI
Computational models of naturally acquired immunity to falciparum malaria$1,122,462
U01 · FY2021 · AI
Computational models of naturally acquired immunity to falciparum malaria$583,316
U01 · FY2021 · AI
Computational models of naturally acquired immunity to falciparum malaria$410,553
U01 · FY2021 · AI
Computational models of naturally acquired immunity to falciparum malaria$1,165,083
U01 · FY2020 · AI
Computational models of naturally acquired immunity to falciparum malaria$591,089
U01 · FY2020 · AI
Immunologic Consequences of Highly Effective Antimalarial Chemoprevention$96,662
K23 · FY2016 · AI · contact PI
Immunologic consequences of highly effective antimalarial chemoprevention$34,828
K23 · FY2016 · AI · contact PI
Immunologic consequences of highly effective antimalarial chemoprevention$131,490
K23 · FY2015 · AI · contact PI
Immunologic consequences of highly effective antimalarial chemoprevention$131,490
K23 · FY2014 · AI · contact PI
Immunologic consequences of highly effective antimalarial chemoprevention$131,490
K23 · FY2013 · AI · contact PI
Immunologic consequences of highly effective antimalarial chemoprevention$131,490
K23 · FY2012 · AI · contact PI